FDA Letters Flag Oprah Video, Morgan Freeman Ad in Crackdown.

The article discusses recent actions taken by US regulators against pharmaceutical companies for allegedly misleading advertising practices, particularly in the context of drug marketing. The Food and Drug Administration (FDA) issued letters to several companies, including Eli Lilly & Co. and Novo Nordisk A/S, highlighting concerns over their promotional materials for obesity drugs Zepbound and Wegovy, as well as other medications. The letters, part of a broader initiative following a memorandum from President Donald Trump, emphasize the need for clearer disclosure of side effects and caution against using misleading imagery in advertisements. The FDA's scrutiny reflects a growing concern about the impact of direct-to-consumer advertising on public understanding of drug risks and benefits. [Extracted from the article]